Form 4: Accelerate Diagnostics Executive Sells Shares to Cover Tax Obligations

Larry Michael Mertz, Chief Technology Officer of Accelerate Diagnostics, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On April 4, 2024, Larry Michael Mertz, the Chief Technology Officer of Accelerate Diagnostics, sold 978 shares of common stock at a price of $0.88 per share.
• This sale was to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Mertz also acquired 2,866 shares of common stock upon the vesting of RSUs on the same day.
• Following these transactions, Mertz beneficially owns 54,457 shares of Accelerate Diagnostics.
• The reported amounts have been adjusted to reflect a 1-for-10 reverse stock split that occurred on July 11, 2023.

Sentiment

Score: 5

Explanation: This is a neutral event. An executive selling shares to cover taxes is a normal part of equity compensation.

Industry Context

This is a routine Form 4 filing, reflecting insider transactions related to equity compensation. It's common for executives to sell shares to cover tax obligations when RSUs vest.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholders, but is unlikely to be significant as it is related to tax obligations.

Key Dates